Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva's flagship spin-off
GENEVA--(BUSINESS WIRE)--The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the Center, as Chief Business Officer and Co-founder of ABILITY Neurotech SA, a pioneering spin-off company translating breakthrough brain-computer interface (BCI) technology into clinical impact.
Thrilled to share that Craig Cook has been named Chief Business Officer of Ability Neurotech SA, our flagship spin-off. A key force behind our venture-building model, Craig will now help Ability Neurotech shape the future of brain-computer interfaces.
During his tenure at the Wyss Center, Craig Cook played a transformative role in establishing a strong business development framework and positioning the organization as a venture builder in neurotechnology. Under his leadership, six breakthrough technologies were successfully spun out into operational startup companies: Clee Medical SA, Brainscape Medical SA, Dataflight Ltd, BrainQuant SA, Aleos Bio SA, and ABILITY Neurotech SA.
In parallel, Craig led the onboarding of aligned startups such as Dandelion Science Corp. and dEEGtal Insights SA, strengthening our AI and neurotech ecosystem. He also contributed to Series A investments in two Wyss-affiliated companies, Artiria Medical SA and Neurosoft Bioelectronics SA, bolstering our commitment to early-stage innovation.
Now joining ABILITY Neurotech SA as Chief Business Officer and Co-founder, Craig will drive the company's fundraising strategy and operational growth. As the Wyss Center's flagship spin-off, ABILITY Neurotech is uniquely positioned to play an important role at the forefront of the brain-computer interface (BCI) revolution, ABILITY Neurotech offers a comprehensive end-to-end solution that spans neural signal capture, processing and seamless integration into clinical practice.
'Craig has been a catalyst for our mission,' said Prof. Erwin Böttinger, Director of the Wyss Center. 'His vision and energy have not only shaped our ecosystem but also brought our technologies closer to the market and to patients who need them. I look forward to seeing the continued impact of his work at ABILITY Neurotech.'
Dr. Tracy Laabs, Head of Innovation and Strategic Partnerships at the Wyss Center, added:
'Craig's transition to lead one of our spin-offs is a clear example of the success of our model. It demonstrates how our translational approach—building and spinning out high-potential startups—can bring cutting-edge neurotechnologies closer to the clinic while empowering talented individuals to lead the next wave of innovation.'
The Wyss Center extends its sincere gratitude to Craig Cook for his leadership and dedication and looks forward to continued collaboration with him in this exciting next chapter.
About Wyss Geneva: Wyss Geneva is a non-profit advancing neurotechnologies to improve lives affected by neurological and mental health disorders. Based at Campus Biotech in Geneva, it develops AI, bioengineering, and neuroengineering solutions to restore neural function and enable precision therapies. Founded in 2014 with the support of philanthropist Hansjörg Wyss, it collaborates globally to drive innovation and clinical impact
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
MRO acquires clinical data management platform Q-Centrix from TPG Growth
US-based clinical data exchange company MRO has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth. Q-Centrix is a comprehensive data management platform designed to reduce complexity, expedite decisions and advance clinical outcomes. MRO said the acquisition would enable hospitals and health systems to convert fragmented clinical data into actionable insights, expediting the exchange of clinical data across the sector. The deal is expected to create scalable value for healthcare providers, payers and life sciences, supporting more precise decision-making and broader clinical applications. MRO CEO Jason Brown said: 'At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today. 'Combining MRO's leading clinical data exchange solutions and Q-Centrix's clinical data management capabilities creates a category-defining, fit-for-purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem.' The combined entity will provide services to more than 2,000 health systems and hospitals, as well as over 7,000 clinics and almost 250 payers. By enriching and curating clinical data, MRO and Q-Centrix aim to deliver scalable value, facilitating precise decision-making and wider clinical applications. Q-Centrix CEO Milton Silva-Craig said: 'MRO and Q-Centrix share a commitment to advancing the industry in service of our customers. 'That focus is fuelling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured, highly valuable data sets to support clinical care, operational performance, breakthrough research, and regulatory compliance. 'Purpose-built around our customers' most pressing needs, this is innovation where it matters most.' The acquisition is supported by healthcare technology investors such as private equity company Parthenon Capital, which has reaffirmed its support for MRO with a new investment. The parties have not disclosed the value of the deal. "MRO acquires clinical data management platform Q-Centrix from TPG Growth" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Simulations Plus price target lowered to $36 from $45 at Craig-Hallum
Craig-Hallum lowered the firm's price target on Simulations Plus (SLP) to $36 from $45 and keeps a Buy rating on the shares following the company's Q3 pre-release and lower FY25 guidance. The firm says that macro headwinds are affecting the company's services segment with customers delaying contract starts, slow walking signing new contracts or pushing out clinical trials. Craig-Hallum notes that although the changes to the business environment are unfortunate, Simulations Plus' software segment is holding up better and the business remains part of a growing market with the implementation of New Approach Methodologies, presenting an attractive opportunity to invest in the future of drug development. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on SLP: Disclaimer & DisclosureReport an Issue Simulations Plus price target lowered to $28 from $42 at Stephens Closing Bell Movers: Oracle jumps 7% after Q4 earnings beat Simulations Plus Announces Q3 Revenue and Strategic Changes Simulations Plus sees Q3 revenue $19M-$20M, consensus $22.83M Simulations Plus cuts FY25 revenue view to $76M-$80M from $90M-$93M Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Congress Is Working on a New Crypto Bill. Here's What Investors Need to Know.
Stablecoins have exploded in popularity, and are now a $250 billion industry. Washington lawmakers are in the process of delivering a final piece of stablecoin legislation before the end of the summer. New legislation should make it more attractive for cryptocurrency investors to get exposure to stablecoins. 10 stocks we like better than Circle Internet Group › In June 2020, the value of the crypto stablecoin industry was $10 billion. Five years later, it's now a $250 billion industry. That makes stablecoins one of the fastest-growing areas of the crypto market right now. In fact, stablecoins have grown so fast and have become so popular that they have attracted the attention of Congress, which is looking for ways to regulate them. There are now two competing pieces of legislation, one in the House and one in the Senate, and the goal is to have a final bill passed before the end of the summer. For crypto investors, this new legislation could have important consequences. In theory, it should make stablecoins much more approachable for the average investor. And it will help to define how stablecoins fit into the world of traditional finance. If Congress is interested in this new stablecoin trend, then you need to be aware of it as well. Before digging into the new stablecoin legislation, it's important to understand what stablecoins are, and how they work. Most stablecoins are pegged 1:1 to the value of the U.S. dollar. As a result, many refer to them as "digital dollars." In theory, you can always exchange $1 worth of stablecoins for $1 in cash. That's what makes them so valuable: They are the easiest way to move between the worlds of traditional finance and blockchain finance. Right now, two stablecoins -- Tether (CRYPTO: USDT) and USDC (CRYPTO: USDC) -- account for approximately 85% of the value of the stablecoin market. But there are plenty of new, up-and-coming stablecoins, including one that has been issued by World Liberty Financial, the crypto venture affiliated with the Trump family. To give you an idea of just how big stablecoins have become, of the top 50 cryptocurrencies (as ranked by market cap), five of them are now stablecoins. The easiest way to spot them is by looking for cryptos trading at a price of exactly $1. In order for stablecoin legislation to be signed into law by President Trump later this summer, congressional lawmakers need to settle their differences about what should be included in the final bill. At the beginning of this year, this seemed like an easy thing to do. But if you've been following all the ruckus around the "Big, Beautiful Bill," it is now obvious that getting the House and Senate to agree on anything these days is challenging. When you add in the fact that a Trump-affiliated crypto venture (World Liberty Financial) is now an emerging player in the stablecoin industry, things get even more complicated. According to Rep. French Hill (R-Ark.), the Chairman of the House Financial Services Committee, there are three major points of contention around stablecoins that need to be ironed out between the two chambers. The first involves the oversight of foreign issuers of stablecoins. Legislators want firm assurances that foreign stablecoin issuers will be held to the same strict standards as U.S. stablecoin issuers. This is important because Tether, the world's largest stablecoin issuer, is not based in the United States. The second involves who has the authority to regulate these stablecoins at both the state and federal levels. Just a year ago, the obvious choice at the federal level would have been the SEC. But it now looks like another regulatory body might get the nod. The third involves who has the right to issue stablecoins. Historically, there has been a firm dividing line between banking and commerce in the United States. Banks and other financial services firms should be able to issue stablecoins, right? But can Silicon Valley tech companies issue stablecoins? And can entities affiliated with political figures issue stablecoins? If you are interested in investing in stablecoins, there are several potential strategies to pursue. The most straightforward approach is to invest in stablecoin issuers themselves. The obvious choice here is Circle Internet Group (NYSE: CRCL), which went public on June 5. Circle is the company behind USDC, the second-largest stablecoin in the world. Or, you might decide to focus on publicly traded companies that are moving aggressively into stablecoins. For example, in August 2023, PayPal (NASDAQ: PYPL) launched a new stablecoin called PayPal USD (CRYPTO: PYUSD), which is currently valued at $1 billion. You could also decide to focus on cryptocurrencies with "companion" stablecoins. For example, Ripple, the company behind the XRP (CRYPTO: XRP) token, issued a companion stablecoin called Ripple USD (CRYPTO: RLUSD) in December 2024. The goal was to spur activity on the XRP blockchain, thereby boosting demand for the XRP token. And, of course, you could invest in stablecoins themselves. This might sound a bit odd at first. Why would you take $1 and invest it in an asset that will always trade for $1? However, new stablecoin yield strategies are exploding in popularity. As a result, you might be able to earn more on that "digital dollar" than on dollars sitting in your bank account. While stablecoins might sound confusing, they are now one of the fastest-growing areas of the crypto world, and can no longer be ignored. With new stablecoin legislation scheduled to be signed later this summer, it should create even more momentum for the top players in this emerging space. Before you buy stock in Circle Internet Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Circle Internet Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $888,780!* Now, it's worth noting Stock Advisor's total average return is 999% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Dominic Basulto has positions in Circle Internet Group, USDC, and XRP. The Motley Fool has positions in and recommends PayPal and XRP. The Motley Fool recommends the following options: long January 2027 $42.50 calls on PayPal and short June 2025 $77.50 calls on PayPal. The Motley Fool has a disclosure policy. Congress Is Working on a New Crypto Bill. Here's What Investors Need to Know. was originally published by The Motley Fool
